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Abstract
Duchenne muscular dystrophy (DMD) is the most prevalent inherited childhood muscle disorder in humans. mdx mice
exhibit a similar pathophysiology to the human disorder allowing for an in-depth investigation of DMD. Myogenin, a
myogenic regulatory factor, is best known for its role in embryonic myogenesis, but its role in adult muscle maintenance
and regeneration is still poorly understood. Here, we generated an mdx:Myog
flox/flox mouse harboring a tamoxifen-inducible
Cre recombinase transgene, which was used to conditionally delete Myog during adult life. After tamoxifen treatment, three
groups of mice were created to study the effects of Myog deletion: mdx:Myog
flox/flox mice (mdx), Myog
flox/flox mice (wild-
type), and mdx:Myog
floxD/floxD:Cre-ER mice (mdx:Myog-deleted). mdx:Myog-deleted mice exhibited no adverse phenotype
and behaved normally. When run to exhaustion, mdx:Myog-deleted mice demonstrated an enhanced capacity for exercise
compared to mdx mice, running nearly as far as wild-type mice. Moreover, these mice showed the same signature
characteristics of muscle regeneration as mdx mice. Unexpectedly, we found that myogenin was dispensable for muscle
regeneration. Factors associated with muscle fatigue, metabolism, and proteolysis were significantly altered in mdx:Myog-
deleted mice, and this might contribute to their increased exercise capacity. Our results reveal novel functions for myogenin
in adult muscle and suggest that reducing Myog expression in other muscle disease models may partially restore muscle
function.
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Introduction
Duchenne muscular dystrophy (DMD) is the most prevalent
childhood muscle disorder in humans, affecting 1 in 3,500
newborn males [1]. DMD is a chronic muscle-wasting disease
that leads to progressive muscle weakness and atrophy. It is caused
by mutations within the dystrophin gene, a critical structural
component of the muscle cell membrane [2]. The physiologic
symptoms of DMD become apparent within the first few years of
life, and muscle strength quickly deteriorates by puberty usually
resulting in early death. Common diagnoses and signs of DMD
include increased blood creatine kinase (CK) concentrations,
increased rates of myofiber regeneration, centrally located
myofiber nuclei, mitochondrial swelling, and ultimately myofiber
necrosis [3]. Animal models for DMD include the mdx mouse,
which has been studied extensively to better understand the
molecular basis of the disease and to develop therapeutic strategies
that might be applicable to humans [4,5,6,7,8,9,10].
As mentioned above, DMD is associated with muscle
metabolism dysfunction and muscle weakness. Neuronal nitric
oxide synthase (nNOS) is a dystrophin-associated protein found
near the muscle sarcolemma, and its expression is greatly reduced
in mdx mice [11]. Recently, investigators have shown that the loss
of interaction between nNOS and phosphofructokinase (PFK)
contributes to glycolytic dysfunction and increased fatigability in
muscular dystrophy [12]. The forced expression of nNOS in mdx
mice enhances muscle endurance and glycogen metabolism [12].
These experiments provide important mechanistic insights into
why mdx mice, as well as DMD patients, experience progressive
muscle weakness associated with muscle atrophy.
Nonhuman mammalian muscle fibers are broadly divided into
subtypes based on their expression of different myosin isoforms:
type-I, type-IIa, IIx/d and type-IIb fibers [13]. Type-I and type-IIa
fibers are primarily oxidative and confer an increased exercise
endurance with a high resistance to muscle fatigue during aerobic
exercise. Type-IIb/type-IIx fibers are glycolytic and allow for
anaerobic sprinting or short bursts of strength but fatigue more
quickly. Type I fibers are commonly referred to as ‘‘slow twitch,’’
whereas type II fibers are known as ‘‘fast twitch.’’ Glucose is a major
energy source for all muscle metabolisms, but glycolytic fibers are
particularly dependent on glucose for energy production [13,14].
Glucose stored as glycogen within skeletal muscle fibers is utilized to
quickly meet the demands of high-intensity exercise. Fatty acids are
the major source of energy utilized during low-intensity exercise.
Lactate is a by-product of anaerobic metabolism and its blood
concentration rises as exercise intensity increases [15].
The maintenance and regeneration of skeletal muscle are
orchestrated by the 4 basic helix-loop-helix myogenic regulatory
factors: MyoD, Myf5, MRF4, and myogenin. Within the last 20
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demonstrated its diverse and relevant functions from embryonic
development through adult life. Myogenin is required for
embryonic skeletal muscle development and for achieving normal
body size after birth [16,17,18]. Myogenin is primarily expressed
in slow-twitch/oxidative myofibers, and when overexpressed, it
has been shown to induce a shift from glycolytic to oxidative
metabolism [19,20]. Recently, myogenin was shown to transcrip-
tionally activate the E3 ubiquitin ligases Fbxo32 and Trim63
following muscle denervation, and the loss of myogenin during
adult life confers a resistance to denervation-induced muscle
atrophy [21]. Moreover, recent results from our laboratory
indicate that myogenin plays a role in regulating skeletal muscle
metabolism and exercise capacity during adult life [22].
In this study, we sought to determine whether the deletion of
myogenin in adult mdx mice would alter mdx muscle regeneration
and exercise endurance capacity. Because myogenin is involved in
muscle growth and regeneration in adult life, we hypothesized that
deleting Myog in mdx mice would greatly exacerbate their muscle
fatigue and wasting condition. Surprisingly, the absence of
myogenin appeared to have no effect on muscle regeneration.
Moreover, the exercise endurance of mdx:Myog-deleted adult mice
was substantially improved compared to that of mdx control mice
and was nearly equal to that of wild-type mice. This favorable
improvement in exercise capacity was associated with alterations
in nNOS and Fbxo32 expression, suggesting a molecular pathway
responsible for improving muscle fatigue resistance.
Current therapies and treatments for DMD, such as corticos-
teriods and orthotics, are limited and only serve to delay the onset
of this progressive muscle disease [23]. New therapeutic strategies
aim to treat DMD at the molecular level, such as gene
replacement therapy and exon skipping [24]. Our results reveal
novel functions for myogenin in adult muscle and suggest that
reducing Myog expression in other muscle disease models may
partially restore muscle function.
Results
Myog is not required for the survival of mdx mice
Earlier, we hypothesized that deleting Myog in mdx mice would
greatly exacerbate their muscle fatigue and wasting condition. To
better understand the role of myogenin in adult skeletal muscle
maintenance and regeneration and to test our hypothesis, we
interbred mice carrying a floxed Myog allele and a tamoxifen-
inducible Cre recombinase transgene (Myog-deleted mice), which
were generated as previously described [17], with mdx mice (mice
carrying the DMD
mdx allele). Wild-type (Myog
flox/flox) and mdx mice
in the same mixed genetic background were also generated as
controls. Cre-expressing adult mice (8–12 wk old) were rendered
Myog-deficient with a single intraperitoneal (IP) injection of
tamoxifen. The efficiency of Myog genomic deletion was
approximately 92% (Figure 1A). Transcript expression analysis
using reverse transcriptase-quantitative polymerase chain reaction
(RT-qPCR) showed that induced expression levels of residual Myog
in mdx:Myog-deleted mice were similar to basal expression levels of
Myog in wild-type mice. Moreover, Myog transcript levels in mdx
mice were 5 times higher than in wild-type mice (controls)
(Figure 1B). This is expected given that mdx mice continuously
regenerate their damaged muscle. mdx:Myog-deleted mice exhib-
ited normal behavior, fed normally, and maintained normal body
weight during a 1.5-year observation period (data not shown).
These results indicate that Myog was not required for the survival
of mdx mice.
mdx:Myog-deleted mice exhibit an enhanced capacity for
exercise compared to mdx mice
Because the loss of myogenin in mdx mice did not result in any
overt phenotypes and because our recent results showed that Myog-
deleted mice have an enhanced capacity for exercise [22], we
performed similar experiments with mdx and mdx:Myog-deleted
mice. Both groups were run on a treadmill until they reached
exhaustion using a high-intensity exercise regimen designed to test
their exercise endurance capacity. Over the course of 3
consecutive days of running, mdx:Myog-deleted mice ran 37%
more than mdx mice, but 11% less than wild-type mice before
reaching exhaustion (Figure 2). These results demonstrate that the
deletion of Myog increased the exercise endurance capacity of mdx
mice.
The absence of myogenin alters blood metabolite
concentrations during exhaustive exercise
We previously found that deletion of Myog enhanced exercise
endurance capacity and that this was associated with alterations in
blood metabolite concentrations [22]. To investigate whether this
phenomenon occurred in mdx:Myog-deleted mice, we determined
their pre- and post-exercise metabolic profiles. Pre-exercise blood
glucose concentrations were approximately equal between wild-
type, mdx, and mdx:Myog-deleted mice. Moreover, in the 3 groups,
these concentrations were virtually unchanged at exhaustion when
compared to their pre-exercise levels (Figure 3A).
Lactate is a by-product of glycolysis, and increased blood lactate
levels at exhaustion are a commonly used indicator of glycolytic
metabolism, whereas basal blood lactate levels at exhaustion are
indicative of oxidative metabolism. Blood lactate levels at
exhaustion were increased in all 3 groups as compared to wild-
type pre-exercise values. However, the blood lactate concentration
level in mdx:Myog-deleted mice was 51% greater than mdx mice and
14% greater than that in wild-type mice (Figure 3B). These results
show that mdx:Myog-deleted mice possessed a higher blood lactate
concentration threshold than mdx and wild-type mice before
reaching exhaustion.
Myog is not required for muscle regeneration in adult
mdx mice
Histology revealed that the muscle morphology of mdx:Myog-
deleted mice was very similar to that of mdx mice. In both
genotypes, we observed classic signs of muscle regeneration, such
as myofibers with widely varying diameters containing centrally
located nuclei (Figure 4A). Morphometric analysis revealed similar
average cross-sectional areas for myofibers from both genotypes
(data not shown). Van Gieson staining for collagen and elastin also
revealed similar patterns of mild fibrosis in mdx and mdx:Myog-
deleted mice (Figure 4B). To analyze the muscle ultrastructure, we
used transmission electron microscopy (TEM). TEM analysis
revealed signs of mitochondrial swelling in both mdx and mdx:Myog-
deleted mice (Figure 4C); a visual inspection of the TEM sections
showed the pathology to be somewhat worse in mdx mice than in
mdx:Myog-deleted mice, as shown by abnormal, less well-defined
sarcomeric Z-lines and swollen mitochondria (Figure 4C). To
determine if the absence of Myog had an effect on the dystrophin-
glycoprotein complex, we measured Creatine Kinase (CK)
activity. Both mdx and mdx:Myog-deleted mice showed dramatically
elevated CK levels compared to wild-type mice (Figure 5). The
results demonstrate that deleting Myog in mdx mice did not reverse
the pathologic effects of muscular dystrophy. Furthermore, we
found that the deletion of Myog in mdx mice did not exacerbate
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regeneration in adult mdx mice.
Myofiber characteristics of mdx:Myog-deleted mice
The deletion of Myog in mdx mice might be expected to cause
alterations in muscle properties such as fiber type proportion and
glycogen content. We performed RT-qPCR analysis to determine
the transcript expression levels of myosin type-I, type-IIa, and
type-IIb isoforms in medial and lateral gastrocnemius muscles
taken from mdx, mdx:Myog-deleted, and wild-type mice. No
differences were detected in the transcript expression levels of
these myosin isoforms between mdx and mdx:Myog-deleted mice
(Figure 6). We confirmed these RT-qPCR results by histological
staining for myosin ATPase activity (data not shown). Glycogen
histochemical staining of gastrocnemius muscle revealed a
qualitative increase in glycogen content in mdx:Myog-deleted
muscle compared to that of mdx and wild-type muscle
(Figure 7A). We attempted to quantify these results by determining
glycogen levels in whole muscle homogenates using a biochemical
assay, but were unable to reliably detect any significant differences
(data not shown). The results indicate that the absence of
myogenin in mdx mice did not cause alterations in myosin isoform
distribution or glycogen content. Therefore, the enhanced exercise
endurance capacity that we observed in mdx:Myog-deleted mice
compared to that in mdx mice was unlikely due to changes in their
muscle properties.
Expression levels of genes regulating muscle fatigue,
metabolism, and proteolysis are altered in mdx:Myog-
deleted mice
To begin elucidating the mechanisms that are responsible for
the enhanced exercise performance observed in mdx:Myog-deleted
mice, we determined the transcript levels of genes whose
expression might be expected to change in the absence of
myogenin. Using RT-qPCR, we determined the transcript levels
of genes that regulate muscle development, metabolic processes,
and muscle proteolysis, namely, Myf5, MyoD, Mrf4, nNOS, PFK,
Hdac4, glycogen synthetase, and muscle glycogen phosphorylase.
In the light of recent findings showing that Trim63 and Fbxo32 are
regulated by myogenin and promote muscle proteolysis and
atrophy, we examined the expression of these genes [21]. Of these,
the expression of Fbxo32 was significantly decreased 1.2 fold (data
not shown) while the expression of nNOS increased 2.2 fold in
gastrocnemius muscle of mdx:Myog-deleted mice compared to that
of mdx mice (Figure 8). Changes in nNOS expression might have
contributed to the enhanced exercise endurance capacity seen in
mdx:Myog-deleted mice over their mdx counterparts. These
alterations in gene expression suggest a mechanistic basis for this
observed physiologic phenomenon.
Discussion
Myogenin is thought to play a critical role in the maintenance
and regeneration of adult skeletal muscle, but only a few studies
supporting this view have been published. The discovery that Myog
is required during embryonic mouse muscle development initially
supported this view [16], and a number of subsequent studies have
further suggested a role for Myog in adult muscle maintenance and
regeneration [18,19,20,25,26,27]. Recently, we developed an
efficient method for conditionally deleting Myog during adult life
[22]. Here, we applied this method to determine if the deletion of
Myog had an effect on mice that were also deficient in dystrophin.
Although the deletion of Myog before the onset of dystrophy may
be of interest, we chose to delete Myog from dystrophic adult mice
to avoid the growth defects observed in Myog-deleted mice [17].
The deletion of Myog in adult mdx mice also allowed us to clearly
define the function of myogenin in adult mdx muscle. While the
prevailing view of Myog would suggest an essential role for Myog in
Figure 2. Enhanced exercise endurance capacity in mdx:Myog-
deleted mice during the high-intensity exercise regimen.
mdx:Myog-deleted mice (n=14) over the course of 3 consecutive days
of running ran 37% more than mdx mice (n=14) and 11% less than
wild-type mice (n=14) under high-intensity exercise conditions. Error
bars represent 1 standard deviation (*p,0.05).
doi:10.1371/journal.pone.0016184.g002
Figure 1. Reduced Myog genomic DNA and transcripts in mdx:Myog-deleted mice. (A) PCR genotyping reveals an efficient deletion (92%) of
Myog genomic DNA in adult mdx:Myog-deleted mice (**p,0.001). (B) Reduced abundance of Myog transcripts in adult mdx:Myog-deleted mice. Myog
transcript levels in mdx mice were increased by 5-fold over those in wild-type mice (*p,0.05). Myog transcript expression in mdx:Myog-deleted mice
was equal to that of wild-type mice. (all groups, n=3 ). Error bars represent 1 standard deviation.
doi:10.1371/journal.pone.0016184.g001
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demonstrated that the absence of Myog in mdx mice did not affect
their behavior or mobility for up to 1.5 years following deletion of
Myog. These results are consistent with our previous results
showing that Myog is dispensable for skeletal muscle maintenance
and regeneration during adult life [17,18] [22].
Because Myog expression is activated upon muscle injury to help
facilitate muscle regeneration and repair [28], and mdx mice exist
in a constant state of muscle regeneration, we anticipated that
Myog transcripts would be upregulated in muscle from mdx mice to
help facilitate muscle regeneration. As expected, Myog transcript
expression levels were dramatically increased in mdx mice but not
in mdx:Myog-deleted mice. As skeletal muscle stem cells are
activated to repair and fuse with existing muscle fibers, Myog
expression increases in the latter stages of differentiation. These
compensatory events result in muscle hypertrophy, which is
characterized by increases in muscle mass, fiber count, centrally
located nuclei, and distribution of the fiber calibers in mdx mice
[10,29,30]. Our results also confirm previously published results
demonstrating that Myog expression is elevated in mdx mice [31].
The efficient deletion of Myog and its subsequent downregulation
in mdx mice did not produce any noticeable adverse effects,
indicating that Myog is not required for survival or progression of
muscular dystrophy. Our results demonstrate that when subjected
to vigorous exercise, mdx mice exhibit a substantial reduction in
exercise endurance capacity compared to wild-type mice.
However, when mdx:Myog-deleted mice were subjected to vigorous
exercise, they ran much farther than the mdx mice and approached
distances ran by wild-type mice. These results are consistent with
our previous findings that Myog-deleted mice have an enhanced
Figure 3. Normal blood glucose but increased blood lactate levels in mdx:Myog-deleted mice after high-intensity exercise. (A) Blood
glucose levels in mdx, mdx:Myog-deleted, and wild-type mice (all groups, n=14) after running to exhaustion under high-intensity exercise conditions.
Baseline (pre-exercise) blood glucose levels were approximately the same for the 3 test groups, ranging from 158 to 177 mg/dL. At exhaustion, blood
glucose levels remained virtually unchanged for all groups. (B) Blood lactate levels were significantly elevated for the 3 test groups at exhaustion
compared to wild-type pre-exercise values. Blood lactate levels at exhaustion in wild-type (n=10) and mdx:Myog-deleted (n=12) mice were
significantly higher than those of mdx mice (n=11). Error bars represent 1 standard deviation (*p,0.05).
doi:10.1371/journal.pone.0016184.g003
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mice, actually benefited from myogenin’s absence.
In our previous study, we found that the deletion of Myog in
adult mice enhanced their exercise endurance by altering their
skeletal muscle metabolism as indicated by increased oxygen
consumption and alterations in blood metabolite concentrations
during exercise [22]. In our current study, we found that, at
exhaustion, mdx:Myog-deleted mice had blood glucose levels similar
to those of wild-type and mdx mice. This was expected because the
high-intensity exercise regimen was designed to employ glycolytic
metabolism, which primarily utilizes liver and muscle glycogen as
a source for glucose. Mice subjected to high-intensity exercise
often reach exhaustion before metabolizing substantial amounts of
liver glycogen, thus leaving blood glucose concentrations at
normal levels. The lack of observable blood glucose depletion in
mdx:Myog-deleted mice suggests that the inherent muscle weakness
in mdx mice limits their exercise endurance capacity, thus allowing
their blood glucose concentration at exhaustion to remain at
normal, pre-exercise levels.
Blood lactate concentrations were elevated in mdx:Myog-deleted
mice compared to the mdx mice following high-intensity exercise.
These results suggest that the loss of myogenin in mdx mice con-
ferred an increased lactate threshold before reaching exhaustion.
Recent studies have shown that, contrary to prevailing views,
lactate production may actually retard muscle acidosis [32,33,34].
The conversion of pyruvate to lactate by lactate dehydrogenase
also produces NAD+. This maintains the NAD+/NADH cytosolic
redox potential, which promotes a substrate flux through glycolysis
and ultimately allows for the continued production of ATP from
glycolysis [35]. Thus, increased blood lactate levels may contribute
to the observed increase in exercise endurance capacity in
mdx:Myog-deleted mice.
mdx mice undergo muscle degeneration due to the absence of
dystrophin at the sarcolemma [8,9,10,11]. These muscle regener-
ation defects are readily apparent after bouts of intense exercise
and generally result in chronic muscle weakness. Given that
mdx:Myog-deleted mice exhibited an enhanced exercise endurance
capacity, we investigated whether their muscles displayed signs of
improved muscle regeneration. We found no remarkable changes
in the muscle histopathology of mdx:Myog-deleted mice compared
to that of mdx mice. Characteristic signs of muscle regeneration,
such as myofibers containing centrally located nuclei and wide
variations in fiber diameter, were observed in both mdx:Myog-
deleted and mdx mice. mdx muscles are also particularly prone to
fibrosis due to the increased production of connective tissue that is
coincident with defective muscle regeneration and muscle atrophy
Figure 4. Histologic evaluation of mdx, mdx:Myog-deleted, and wild-type hindlimb muscle. (A) Hematoxylin and eosin-stained mdx and
mdx:Myog-deleted muscle sections both displayed classic characteristics of regeneration, which include wide variations in myofiber diameter and
centrally located nuclei, that were not observed in wild-type samples. (B) Van Gieson staining for collagen and elastin revealed similar levels of fibrosis
in mdx and mdx:Myog-deleted muscle sections that were not observed in wild-type samples. (C) Ultrastructural analysis with TEM showed that
mdx:Myog-deleted muscle sections have reduced mitochondrial swelling when compared to mdx samples. Arrows point out mitochondria. Arrow
heads point out sarcomeric Z-lines; note the abnormal Z-lines in mdx muscle.
doi:10.1371/journal.pone.0016184.g004
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tissue from the muscles of mdx:Myog-deleted mice compared to
those of mdx mice. However, on visual inspection, the muscles from
mdx:Myog-deleted mice showed signs of reduced mitochondrial
swelling and necrosis. Elevated CK levels due to the leakage of CK
through the damaged sarcolemma are also characteristic of
dystrophic muscle [36]. We observed dramatically elevated blood
CK levels in both mdx:Myog-deleted and mdx mice compared to
those in wild-type mice. Given that CK levels in mdx:Myog-deleted
mice remained elevated after the deletion of Myog, one could
conclude that the sarcolemmal defects normally associated with
dystrophin deficiency were likely not repaired in these mice.
Although mdx:Myog-deleted mice displayed enhanced exercise
endurance capacity than mdx mice, their histopathology was
similar to that of mdx mice. Unexpectedly, mdx mice did not display
an increased penetrance of muscular dystrophy following the
deletion of Myog. mdx:MyoD-null mice exhibit a severe dorsal-
ventral curvature of the spine, become progressively less active,
and incur premature death [37]. Our results show that the loss of
myogenin had no effect on muscle regeneration, which suggests
that myogenin is dispensable for this process in adult mdx mice.
In mammalian muscle, enhanced exercise endurance is typically
associated with increases in type-I and type-IIa muscle fibers as
well as increases in muscle glycogen content [38]. Although we
found a relative shift from type-II to type-I myofibers in mdx mice,
the deletion of Myog in mdx mice did not alter these proportions.
Glycogen content levels showed an increasing trend in mdx:Myog-
deleted muscle in our PAS staining. Because the qualitative
analysis of glycogen content could not be confirmed with a more
quantitative biochemical assay, we conclude that glycogen content
was unchanged in whole-muscle homogenates. Nevertheless, this
did not appear to influence the increase in exercise endurance of
mdx:Myog-deleted mice or the possibility that muscle glycogen
content increases locally. Based upon our recent findings that mice
lacking myogenin exhibit increased glycogen utilization and
oxygen consumption during exercise [22], mdx:Myog-deleted mice
are also likely to have similar physiological changes that contribute
to their enhanced exercise endurance. We did not detect any
changes in the expression of muscle glycogen synthetase or
glycogen phosphorylase between mdx:Myog-deleted and mdx mice.
Thus, mdx:Myog-deleted mice exhibit a higher exercise endurance
capacity than mdx mice, yet they display myofiber characteristics
similar to those of mdx mice.
Dystrophin deficiency confers a complex pathophysiology in mdx
mice due to the secondary loss of other factors associated with the
dystrophin-glycoprotein complex [12]. In fact, 80–90% of all
dystrophin-glycoprotein–associated factors are absent in mdx mice
[11]. These factors are synthesized normally, but in the absence of
Figure 6. Myosin expression levels in mdx, mdx:Myog-deleted,
and wild-type hindlimb muscle. No significant differences in
transcript expression values, as assessed by RT-qPCR, for myosin
isoforms type-I, type-IIa, and type-IIb were observed between mdx
(n=3) and mdx:Myog-deleted (n=3) mice. Slight but significant
alterations in myosins type-IIa and type-IIb were detected between
wild-type (n=3) and mdx:Myog-deleted mice. Error bars represent 1
standard deviation (*p,0.05).
doi:10.1371/journal.pone.0016184.g006
Figure 5. Elevated blood CK levels in mdx and mdx:Myog-
deleted mice. A biochemical assay was used to determine the
activities of CK in mdx (n=10), mdx:Myog-deleted (n=9), and wild-type
(n=6) mice. mdx mice exhibited an elevated level of CK prior to exercise
compared to that of wild-type mice. Similarly, mdx:Myog-deleted mice
showed elevated levels of CK prior to exercise. Error bars represent 1
standard deviation (*p,0.05).
doi:10.1371/journal.pone.0016184.g005
Figure 7. Similar muscle glycogen content in mdx and mdx:Myog-deleted mice. Glycogen staining showed similar levels of glycogen in mdx
and wild-type gastrocnemius muscles, but suggested that mdx:Myog-deleted muscle had an increased trend towards glycogen content.
doi:10.1371/journal.pone.0016184.g007
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sarcolemma correctly and are thus targeted for degradation [39].
One of these factors is nNOS. nNOS-deficient mice have been
shown to be unable tooppose vasoconstriction, resultinginischemia
and increased fatigability [40,41]. Furthermore, nitric oxide (NO)
has been shown to regulate neuromuscular transmission [42] as well
astopromotemitochondrialbiogenesis[43]andglucosetransporter
type 4 expression and transport [44], suggesting that reduced NO
production may contribute to the early onset of fatigue [45].
Recently, Wehling-Henricks et al. showed that a loss of
interaction between nNOS and PFK contributes to glycolysis
defects and increased fatigability in mdx mice [12]. Given these
results, we sought to determine whether nNOS and PFK
expression would be affected by the deletion of Myog in mdx mice.
Although the upregulation of nNOS expression in mdx:Myog-
deleted muscle was modest compared to that in wild-type muscle,
it was considerably higher than that in mdx muscle. The increase in
nNOS expression in mdx:Myog-deleted mice might therefore
contribute to the reduced fatigability observed in these mice and
could partially explain their enhanced exercise endurance capacity
compared to that of mdx mice.
With the current study, we extended the relevance of the mdx
mouse model for investigating human DMD by demonstrating that
the exercise endurance capacity of mdx mice is considerably lower
than that of wild-type mice. The decrease in exercise endurance
capacity that we observed in mdx mice is similar to the muscle
weakness typically observed inDMDpatients and is likely caused by
similar mechanisms. In mdx:Myog-deleted mice, the enhanced
exercise endurance was associated with increased expression of
nNOS, a known regulator of muscle fatigue and atrophy. Because
we did not find any histopathologic differences between mdx and
mdx:Myog-deleted mice, we speculate that the absence of myogenin
may rescue mdx:Myog-deleted mice from their inherent glycolytic
dysfunction and muscle weakness, allowing for increased muscle
endurance. Our study’s findings suggest that reducing the
expression of Myog in mdx mice by means other than gene knockout
could provide new directions for achieving partial restoration of
muscle function in other disease models.
Materials and Methods
Ethics Statement
All experimental procedures described in this study followed the
U.S. Public Health Service Policy of Humane Care and Use of
Laboratory Animals and were approved by the Institutional
Animal Care and Use Committee of The University of Texas MD
Anderson Cancer Center (ACUF ID#: 01-92-00237).
Generation of mdx:Myog-deleted mice
For this study, we interbred mice that were homozygous for the
Myog
flox allele and hemizygous for the CAGGCre-ER transgene
[17,46] with C57BL/10ScSn-Dmd
mdx/J mice (Jackson Labs) [4,47].
Thus, mdx:Myog
flox/flox mice were from a mixed background of B6,
B10, and 129 strains. A control strain in the same background but
wild-type for DMD was also generated. Sequencing analysis was
performed to differentiate between mice carrying the Dmd
mdx
allele(s)andwild-type mice(mdx genotyping protocoldetails maybe
obtained by contacting the corresponding author). After tamoxifen
treatment, three groups of mice were created to study the effects of
Myog deletion: mdx:Myog
flox/flox mice (mdx), Myog
flox/flox mice (wild-
type), and mdx:Myog
floxD/floxD:Cre-ER mice (mdx:Myog-deleted).
Efficient deletion of Myog genomic DNA in 8 to 12 week old mice
was achieved by a single injection of tamoxifen dissolved in corn oil
at a concentration of 10mg/40g body weight. Genomic DNA
deletion is determined 2 weeks following the deletion of Myog via
qPCR. Deletion is initially tested in tail clippings and later
confirmed in muscle tissue. To measure deletion efficiency, we
used ABI Power SYBR and the followingprimers: Myog-LoxP-Fwd
(5-CCG GGT AGG AGT AAT TGA AAG GA-3) and Myog-
LoxP-Rev (5- GCC GTC GGC TGT AAT TTG AT -3). An ABI
7500 Fast Real Time PCR System was used to perform qPCR
analysis using default conditions (95uC610 min, 40 cycles of
[95uC615s, 60uC660s]). Unless otherwise stated, all analyses were
performed on mice at 3 to 4 months of age.
Maximal Exercise Endurance Capacity
Treadmill exercise regimes we derived from previously published
protocols [48]. Adult wild-type and Myog-deleted mice were run on
a rodent treadmill (Columbus Instruments Animal Treadmill: Exer
3/6). This treadmill is equipped with a rear electrical stimulus grid
set to deliver 0.2 mA, an uncomfortable but not physically harmful
shock. Mice were determined to have reached the point of
exhaustion when they made contact with the grid for a period of
10 seconds. The stimulus was then shut off in the lane of the
exhausted mouse. The high-intensity exercise regime consisted of a
warmup period of 10 minutes at 10m/min on a ten degree incline.
The speed was then increased by 2 m/min every 2 minutes while
maintaining a 10u incline until exhaustion. Exercise duration,
distance, and maximum speed were recorded at exhaustion.
Figure 8. Altered expression of nNOS in mdx, mdx:Myog-
deleted, and wild-type hindlimb muscle. RT-qPCR analysis
demonstrated that transcript levels of nNOS were reduced in mdx
mice (n=3). Expression of nNOS was increased 2.2-fold in mdx:Myog-
deleted mice (n=3) compared to that in mdx mice. Error bars represent
1 standard deviation (*p,0.05).
doi:10.1371/journal.pone.0016184.g008
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concentrations
Blood lactate concentrations were measured using a Lactate Pro
blood lactate test meter (Arkray USA, Edina, MN) in mice before
exercise and within 30 s after reaching exhaustion. Blood glucose levels
were determined using a Precision Xtra glucometer (Abbott Labs,
Chicago, IL) in mice before exercise and within 30 s after reaching
exhaustion. Tail-vein blood extraction was used to determine blood
lactate and glucose levels immediately after exhaustion.
Histology
Hind-limb muscles were dissected and flash frozen in LN2-
cooled isopentane. Ten to 12 mm fresh-frozen sections were then
cut on a Microm HM 560 Cryostat. H&E Staining was performed
as described previously [17].
Glycogen Stain: The Periodic Acid-Schiff Staining System from
Sigma-Aldrich was utilized for this assay. Sections were hydrated
with deionized water, fixed with 10% neutral buffered formalin for
30 minutes, and then incubated in Periodic Acid Solution for
5 minutes at room temperature. Sections were then rinsed in
distilled water and incubated in Schiff’s Reagent for 15 minutes at
room temperature. Slides were then washed in running tap water
for 5 minutes and counterstained in Hematoxylin Solution for
90 seconds. Slides were again washed in running tap water,
dehydrated in ascending alcohols, cleared with 2 exchanges of
Xylene, and mounted.
Fibrosis stain for Collagen and Elastin: Muscle sections were
hydrated with deionized water and then fixed for 30 minutes in
neutral buffered formalin. Slides were then incubated in Working
Elastic Stain Solution for 10 minutes (20 mL Hematoxylin
Solution, 3 mL Ferric Cholride Solution, 8mL Weigert’s Iodine
Solution, 5 mL Deionized water). Slides were then washed in
deionized water and incubated in Wokring Ferric Chloride
Solution for 1 minute (3mL Ferric Chloride Solution, 37 mL
deionized water). Sections were then washed in tap water followed
by rinsing in 95% alcohol. Slides were then rinsed in deionized
water, incubated in Van Gieson Solution for 5 minutes, rinsed in
95% alcohol, dehydrated in ascending alcohols, cleared with 2
exchanges of Xylene, and mounted.
Transmission Electron Microscopy
Samples were fixed with a solution containing 3% glutaraldehyde
plus 2% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.3, for
1 hour. After fixation, the samples were washed and treated with
0.1% Millipore-filtered cacodylate buffered tannic acid, post-fixed
with 1% buffered osmium tetroxide for 30 min, and stained en bloc
with 1% Millipore-filtered uranyl acetate. The samples were
dehydrated in increasing concentrations of ethanol, infiltrated,
and embedded in LX-112 medium. The samples were polymerized
in a 70 C oven for 2 days. Ultrathin sections were cut in a Leica
Ultracut microtome (Leica, Deerfield, IL), stained with uranyl
acetate and lead citrate in a Leica EM Stainer, and examined in a
JEM 100 transmission electron microscope (JEOL, USA, Inc.,
Peabody, MA) at an accelerating voltage of 80 kV. Digital images
were obtained using AMT Imaging System (Advanced Microscopy
Techniques Corp, Danvers, MA).
Biochemical determination of glycogen content
Soleus and extensor digitorum longus (EDL) muscles were
harvested from wild-type, mdx,a n dmdx:Myog-deleted mice. An
abbreviated protocol followed from MBL International Corpora-
tion (www.mblintl.com) includes the following steps: muscles
were isolated and snap frozen in liquid nitrogen. Muscle was
homogenized in dH2O, boiled for 5 minutes, and centrifuged at
13,000rpm for 5min. Glucoamylase hydrolysis enzyme mix was
then added to the supernatants. A master mix of development
buffer, development enzyme mix, and OxiRed probe were then
added to the samples and left to incubate at room temperature
protected from light for 30 minutes. Samples were then measured
colorimetrically using a spectrophotometer at a wavelength of
570nm. Non-hydrolysis control readings were then subtracted from
the experimental raw values, and glycogen concentration was
determined by applying the final values to a standard curve.
RNA isolation and reverse transcriptase-quantitative PCR
RNA was isolated from dounce-homogenized mouse skeletal
muscle or liver using the Invitrogen Trizol kit. Reverse
transcription reactions were performed used Applied Biosystems
RNA to cDNA kits. Power SYBR green, TaqMan master mix,
and Taqman gene expression assays were purchased from Applied
Biosystems (Foster City, CA) and used to determine cDNA
abundance for each gene analyzed. An ABI 7500 Fast Real Time
PCR System was used to perform qPCR analysis using default
conditions (95uC610 min, 40 cycles of [95uC615s, 60uC660s]).
Taqman hydrolysis primer and probe gene expression assays were
ordered with the following assay IDs: Myog, Assay ID:
Mm00446194_m1; Gapdh, Assay ID: Mm03302249_g; Myod1,
Assay ID Mm00440387_m1; Myf5, Assay ID Mm00435125_m1;
Mrf4, Assay ID Mm00435126_m1; myosin 2a, Assay ID:
Mm00454982_m1; myosin, heavy polypeptide 7, cardiac muscle,
beta, Assay ID: Mm00600555_m1; myosin, heavy polypeptide 4,
skeletal muscle, Assay ID: Mm01332541_m1; muscle glycogen
phosphorylase, Assay ID: Mm00478582_m1; glycogen synthase 1,
muscle, Assay ID: Mm00472712_m1; trim63, Assay ID:
Mm01185221_m1; Fbxo32, Assay ID: Mm00499523_m1; Hdac4,
Assay ID: Mm01299557_m1; nNOS, Assay ID: Mm0043517-
5_m1; Pfkfb3, Assay ID Mm00504650_m1.
Determination of blood creatine kinase concentration
To determine blood creatine kinase concentration, the Creatine
Kinase-SL Assay Kit was used (Cat. No. 326-10/30, Genzyme).
Briefly, fresh, clear, unhemolysed blood was first collected via tail-
vein extraction. The serum was next separated from the sample by
centrifugation and cooled on ice. The serum was then mixed with
buffer reagents from the kit (R1 and R2) and the change in
absorbance was spectrophotometrically measured at 340nm until
the change in absorbance was constant. The change in absorbance
values were then converted to Creatine Kinase (U/L) using the
formula supplied with the kit.
Statistical analysis
Statistical analyses were performed using 2-tailed pooled
Student’s t-tests in Microsoft Excel 2008. P,0.05 was considered
to be statistically significant.
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